New search | Conferencedetail
mail
Print view
 
 

Liquid Biopsy Surveillance and Early Detection Summit

Evvnt Promotion / evvnt
-
16.11.2022 - 17.11.2022  Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 07:30 - 16:00
 
Conference themes
In the wake of new FDA guidance and exciting MRD partnership announcements between Grail and AstraZeneca, Amgen and Bristol Myers Squibb the liquid biopsy industry is experiencing a paradigm shift. Touted as having the potential to transform clinical practice as we know it, technical progress and mounting investment in premetastatic applications are creating huge industry-wide excitement for liquid biopsy-based screening and surveillance for novel precision drug development.
Professional congress organizer (PCO)
Hanson Wade
Notes
Brochure: https://go.evvnt.com/1315351-3?pid=4832

Speakers: Aadel Chaudhuri, Assistant Professor of Radiation Oncology, Washington University School of Medicine, and more.
 

Enquiries and Registration:

https://go.evvnt.com/1315351-2?pid=4832
Mr. Alex Domingo
 
Categories
General Medicine
Languages
English
Congress fees
Drug Developers and Academics Conference Pass: USD 0.50, Commercial Vendors Conference Pass: USD 3599.00, Technical Vendors Conference Pass: USD 2599.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

AGEM - Arbeitsgemeinschaft Ethnologie und MedizinEuropean Public Health Association (EUPHA)Ärzte der WeltÖsterreichische Gesellschaft für Public HealthÖsterreichische Akademie der ÄrzteCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÖsterreichisches Rotes KreuzAnästhesie in Entwicklungsländern e. V.